help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Correction for Delmas et al., J Clin Endocrinol Metab 92 (4) 1296-1304.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 6 2285
Copyright © 2007 by The Endocrine Society


Announcement and Resource

Erratum

In the article "Effect of Monitoring Bone Turnover Markers on Persistence with Risedronate Treatment of Postmenopausal Osteoporosis" by Pierre D. Delmas, Bernard Vrijens, Richard Eastell, Christian Roux, Huibert A. P. Pols, Johann D. Ringe, Andreas Grauer, David Cahall, Nelson B. Watts, on behalf of the Improving Measurements of Persistence on Actonel Treatment (IMPACT) Investigators (The Journal of Clinical Endocrinology & Metabolism 92:1296–1304), there was an error in the tabular portion of Fig. 5Go. The arrows next to ‘BTM‘ (a downward arrow in the third row and an upward arrow in the fifth row) were omitted. The corrected figure and legend are printed below. The printer regrets the error.


Figure 5
View larger version (14K):
[in this window]
[in a new window]

 
FIG. 5. Kaplan-Meier survival curves to show effect of feedback (uNTX) based on persistence (n = 2302). Because the reinforcement message delivered at wk 13 and 25 could be different for the same patient, graphical representation of the model was assessed by classifying the patients in RE+ into three message categories: good, more than 30% decrease from baseline in uNTX at wk 10 and 22; stable, at least one stable uNTX response at wk 10 or 22 and no increase in uNTX more than 30%; and poor, at least one uNTX increase more than 30% at wk 10 or 22. The numbers of visits corresponding to good uNTX response (1369 visits) or stable uNTX response (639 visits) were higher than those corresponding to a poor uNTX response (98 visits).

 





This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals